Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05SWY
|
||||
Former ID |
DNC005858
|
||||
Drug Name |
3-Dimethylaminomethyl-1H-indol-4-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527668] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H14N2O
|
||||
Canonical SMILES |
CN(C)CC1=CNC2=C1C(=CC=C2)O
|
||||
InChI |
1S/C11H14N2O/c1-13(2)7-8-6-12-9-4-3-5-10(14)11(8)9/h3-6,12,14H,7H2,1-2H3
|
||||
InChIKey |
YJJMKVPZBCHYHD-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527668] | |
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527668] | ||
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527668] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.